KaroDENTA, UAB - financials and debts

Company age: 15 y. 4 mo.

Update

KaroDENTA - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 0 1,735 4,551 6,906 13,417 7,544 33,921 30,898
Profit before tax -10,574 -14,361 -6,713 -38,078 -15,143 -16,177 10,910 7,093
Net profit -10,574 -14,361 -6,713 -38,078 -15,143 -16,177 10,910 7,093
Equity -13,409 -27,770 -32,868 -70,994 -86,193 -102,370 -91,459 -84,366
Liabilities 3,392 2,501 3,652 227 466 196,724 202,478 170,718
Non-current assets 157,716 157,716 157,716 119,249 106,182 93,049 79,915 66,849
Current assets 5,166 714 2,767 3,183 3,290 1,305 31,104 19,503
Total assets 162,882 158,430 160,483 122,432 109,472 94,354 111,019 86,352
Taxes paid
STI taxes - - - - - 3,498 4,018 4,193
Social insurance contributions - - - - - 328 - -
Financial indicators
Revenue change y/y - - +162.3% +51.7% +94.3% -43.8% +349.6% -8.9%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -6.5% -9.1% -4.2% -31.1% -13.8% -17.1% 9.8% 8.2%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - - - - - - - -
Profit margin Net profit margin. Shows the overall profitability of the company. - -827.7% -147.5% -551.4% -112.9% -214.4% 32.2% 23.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - -827.7% -147.5% -551.4% -112.9% -214.4% 32.2% 23.0%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - - - - - - -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - 578 1,606 3,453 5,552 2,105 14,036 14,260

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

KaroDENTA - Social security debts

From To Debt, €
2026-07-19 2026-07-21 28.26
2026-07-16 2026-07-17 28.26
2026-01-16 2026-01-25 0.21
2026-01-01 2026-01-14 0.21
2025-12-16 2025-12-30 0.21
2025-09-16 2025-09-30 0.07
2025-09-07 2025-09-14 0.07
2025-08-31 2025-09-03 0.07
2025-08-19 2025-08-29 0.07
2025-07-28 2025-08-12 0.07
2025-07-24 2025-07-27 41.33
2025-07-16 2025-07-23 41.26
2025-05-16 2025-05-18 40.35
2025-04-16 2025-04-16 37.91
2024-12-17 2024-12-17 25.77
2024-07-24 2024-08-15 34.24
2024-07-16 2024-07-23 34.20
2024-06-18 2024-06-18 30.79
2024-04-23 2024-05-15 0.06
2024-04-16 2024-04-22 4.10
2024-03-18 2024-03-21 22.60
2024-01-16 2024-01-18 0.05
2023-12-19 2024-01-11 0.05
2023-12-18 2023-12-18 2.25
2023-10-17 2023-11-13 0.31
2023-09-18 2023-10-12 0.31
2023-08-17 2023-09-05 0.31
2023-07-28 2023-08-15 0.31
2023-07-24 2023-07-25 0.32
2023-06-16 2023-06-26 41.70
2023-05-02 2023-05-14 0.02
2023-04-18 2023-04-28 0.02
2023-02-17 2023-04-10 0.02
2023-02-06 2023-02-12 0.02
2023-01-24 2023-02-03 0.02
2022-11-17 2022-11-18 11.11

KaroDENTA - VMI tax arrears

From To Overdue, €
2026-06-18 2026-06-30 1470.81
2026-04-01 2026-06-17 0.81
2025-06-27 2025-09-11 0.28
2025-03-24 2025-06-17 1.12
2025-03-20 2025-03-20 1047.3
2025-02-20 2025-03-19 0.3
2024-10-01 2025-01-29 0.3

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
KaroDENTA, UAB (code 302629920) is a Private Limited Liability Company engaged in wholesale of pharmaceutical and medical goods. In 2025, revenue was €30.9K, down 8.9% year on year from €33.9K in 2024, but well above €7.5K in 2023, showing a strong two-year expansion from a low base. Net profit in 2025 reached €7.1K, compared with €10.9K in 2024 and a loss of €16.2K in 2023, so the company remained profitable despite weaker sales. The 2025 profit margin was 23.0%. Total assets declined to €86.4K from €111.0K in 2024, while liabilities decreased to €170.7K from €202.5K. Equity stayed negative at €84.4K below zero, indicating continued balance sheet pressure. Long-term assets stood at €66.8K and short-term assets at €19.5K. For 2025, ROA was 8.2%, ROE was -8.4%, asset turnover was 0.36x, and revenue per employee was €15.4K.